Investments
6Portfolio Exits
2
Want to inform investors similar to D. Blech & Co. about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
D. Blech & Co. Investments
6 Investments
D. Blech & Co. has made 6 investments. Their latest investment was in Alexion, AstraZeneca Rare Disease as part of their Series D on December 12, 1994.
D. Blech & Co. Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
12/23/1994 | Series D | Alexion, AstraZeneca Rare Disease | $3.8M | No | Amerindo Investment Advisors, Connecticut Seed, D. Blech & Co., HealthInvest Equity Partners, Invesco, Oak Investment Partners, and Undisclosed Investors | 1 |
10/1/1993 | Series C | |||||
6/5/1993 | Series B | |||||
12/4/1992 | Series A | |||||
12/1/1992 | Seed |
Date | 12/23/1994 | 10/1/1993 | 6/5/1993 | 12/4/1992 | 12/1/1992 |
|---|---|---|---|---|---|
Round | Series D | Series C | Series B | Series A | Seed |
Company | Alexion, AstraZeneca Rare Disease | ||||
Amount | $3.8M | ||||
New? | No | ||||
Co-Investors | Amerindo Investment Advisors, Connecticut Seed, D. Blech & Co., HealthInvest Equity Partners, Invesco, Oak Investment Partners, and Undisclosed Investors | ||||
Sources | 1 |
D. Blech & Co. Portfolio Exits
2 Portfolio Exits
D. Blech & Co. has 2 portfolio exits. Their latest portfolio exit was Alexion, AstraZeneca Rare Disease on February 28, 1996.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
2/28/1996 | IPO | Public | |||
Date | 2/28/1996 | |
|---|---|---|
Exit | IPO | |
Companies | ||
Valuation | ||
Acquirer | Public | |
Sources |
D. Blech & Co. Team
2 Team Members
D. Blech & Co. has 2 team members, including current Chief Financial Officer, Berryl Septimus.
Name | Work History | Title | Status |
|---|---|---|---|
Berryl Septimus | Chief Financial Officer | Current | |
Name | Berryl Septimus | |
|---|---|---|
Work History | ||
Title | Chief Financial Officer | |
Status | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.